miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and SRC

Cancer Research - United States
doi 10.1158/0008-5472.can-14-0795
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2014English

The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2014English

The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells

Journal of Urology
Urology
2015English

Androgen Receptor Corepressors and Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

The Androgen Receptor and Prostate Cancer Invasion

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2006English

NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

American Journal of Pathology
Forensic MedicinePathology
2009English

Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2012English

Androgen Receptor Splice Variant-7 Expression Emerges With Castration Resistance in Prostate Cancer

Journal of Clinical Investigation
Medicine
2018English

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy